|
MMD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.241500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.629400E-01 |
| Normal-vs-Stage2 |
1.179640E-01 |
| Normal-vs-Stage3 |
1.056030E-02 |
| Normal-vs-Stage4 |
8.024100E-02 |
| Stage1-vs-Stage2 |
2.190200E-01 |
| Stage1-vs-Stage3 |
2.738300E-02 |
| Stage1-vs-Stage4 |
1.118000E-01 |
| Stage2-vs-Stage3 |
5.599400E-01 |
| Stage2-vs-Stage4 |
3.252000E-01 |
| Stage3-vs-Stage4 |
5.380600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.116930E-03 |
| Normal-vs-AfricanAmerican |
8.853500E-02 |
| Normal-vs-Asian |
2.812800E-01 |
| Caucasian-vs-AfricanAmerican |
6.977400E-01 |
| Caucasian-vs-Asian |
4.473200E-01 |
| AfricanAmerican-vs-Asian |
4.168200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.128200E-02 |
| Normal-vs-Female |
1.812890E-04 |
| Male-vs-Female |
5.378700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.529900E-02 |
| Normal-vs-Extreme_Weight |
5.184000E-01 |
| Normal-vs-Obese |
1.597530E-03 |
| Normal-vs-Extreme_Obese |
8.165000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.073800E-02 |
| Normal_Weight-vs-Obese |
4.888600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.079900E-02 |
| Extreme_Weight-vs-Obese |
3.604700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.893000E-01 |
| Obese-vs-Extreme_Obese |
8.258100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.232110E-02 |
| Normal-vs-Age(41-60Yrs) |
5.180600E-04 |
| Normal-vs-Age(61-80Yrs) |
7.338200E-02 |
| Normal-vs-Age(81-100Yrs) |
6.794600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.775500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.226500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.054220E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.857900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.699800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.102180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.714100E-02 |
| Normal-VS-Type2 PRCC |
3.663600E-02 |
| Normal-VS-KIRP CIMP |
2.435800E-04 |
| Normal-VS-Unclassified PRCC |
5.260300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.013400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.604800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.977400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.219100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.954000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.398600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.969400E-01 |
| Normal-vs-N1 |
6.001700E-04 |
| Normal-vs-N2 |
1.828360E-01 |
| N0-vs-N1 |
1.863800E-03 |
| N0-vs-N2 |
2.073600E-01 |
| N1-vs-N2 |
6.487400E-01 |
|
|
